Clinical Trial Detail

NCT ID NCT01822015
Title Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Thomas Jefferson University
Indications

acute myeloid leukemia

Therapies

Cytarabine + Idarubicin + Sirolimus

Age Groups: adult

No variant requirements are available.